Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs BAH✓SelectedUSD · BAHGSK vs BAH performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs BAH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.3%
BAH return
+183.8%
Excess return
-86.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioBAHExcessAlpha
1D-1.6%-1.7%+0.1%-1.3%
7D-4.7%-4.4%-0.3%-4.0%
30D-4.7%+11.0%-15.7%-6.4%
3M-8.8%+5.5%-14.3%-9.7%
6M-4.6%+9.7%-14.3%-6.6%
YTD+1.0%+0.9%+0.1%-0.6%
1Y+6.9%+5.8%+1.0%+4.1%
3Y+52.5%-30.5%+83.0%+56.4%
5Y+40.3%+4.7%+35.6%+28.8%
All+97.3%+183.8%-86.5%+58.1%

Cumulative growth

Daily Returns

Daily percentage return beside BAH.

Daily Out/Under-Performance

Portfolio return minus BAH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BAH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded BAH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling